| 1 |
Mot YY, Moses EJ, Mohd Yusoff N, Ling KH, Yong YK, Tan JJ. Mesenchymal Stromal Cells-Derived Exosome and the Roles in the Treatment of Traumatic Brain Injury. Cell Mol Neurobiol 2023;43:469-89. [PMID: 35103872 DOI: 10.1007/s10571-022-01201-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 2 |
Roudi S, Rädler JA, El Andaloussi S. Therapeutic potential of extracellular vesicles in neurodegenerative disorders. Handb Clin Neurol 2023;193:243-66. [PMID: 36803815 DOI: 10.1016/B978-0-323-85555-6.00017-5] [Reference Citation Analysis]
|
| 3 |
Mohamed Rasheed ZB, Nordin F, Wan Kamarul Zaman WS, Tan YF, Abd Aziz NH. Autologous Human Mesenchymal Stem Cell-Based Therapy in Infertility: New Strategies and Future Perspectives. Biology (Basel) 2023;12. [PMID: 36671799 DOI: 10.3390/biology12010108] [Reference Citation Analysis]
|
| 4 |
Mathur A, Taurin S, Alshammary S. The Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes- A Literature Review. Diabetes Metab Syndr Obes 2023;16:769-77. [PMID: 36941907 DOI: 10.2147/DMSO.S392161] [Reference Citation Analysis]
|
| 5 |
Lachaud CC, Cobo-Vuilleumier N, Fuente-Martin E, Diaz I, Andreu E, Cahuana GM, Tejedo JR, Hmadcha A, Gauthier BR, Soria B. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses. Front Cell Dev Biol 2023;11:1089817. [PMID: 36875761 DOI: 10.3389/fcell.2023.1089817] [Reference Citation Analysis]
|
| 6 |
Niebergall-Roth E, Frank NY, Ganss C, Frank MH, Kluth MA. Skin-Derived ABCB5(+) Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. Int J Mol Sci 2022;24. [PMID: 36613507 DOI: 10.3390/ijms24010066] [Reference Citation Analysis]
|
| 7 |
Drvenica IT, Stančić AZ, Maslovarić IS, Trivanović DI, Ilić VL. Extracellular Hemoglobin: Modulation of Cellular Functions and Pathophysiological Effects. Biomolecules 2022;12:1708. [DOI: 10.3390/biom12111708] [Reference Citation Analysis]
|
| 8 |
Cequier A, Vázquez FJ, Romero A, Vitoria A, Bernad E, García-martínez M, Gascón I, Barrachina L, Rodellar C. The immunomodulation–immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility. Front Vet Sci 2022;9:957153. [DOI: 10.3389/fvets.2022.957153] [Reference Citation Analysis]
|
| 9 |
Koch DW, Schnabel LV, Ellis IM, Bates RE, Berglund AK. TGF-β2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-03172-9] [Reference Citation Analysis]
|
| 10 |
Karpenko D, Kapranov N, Bigildeev A. Nestin-GFP transgene labels immunoprivileged bone marrow mesenchymal stem cells in the model of ectopic foci formation. Front Cell Dev Biol 2022;10:993056. [DOI: 10.3389/fcell.2022.993056] [Reference Citation Analysis]
|
| 11 |
Lee NK, Myeong SH, Hwang JW, Sa JK, Son HJ, Kim HJ, Jang H, Chang JW, Na DL. Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer’s Disease. Biomedicines 2022;10:1882. [DOI: 10.3390/biomedicines10081882] [Reference Citation Analysis]
|
| 12 |
Jeske R, Liu C, Duke L, Canonicco Castro ML, Muok L, Arthur P, Singh M, Jung S, Sun L, Li Y. Upscaling human mesenchymal stromal cell production in a novel vertical-wheel bioreactor enhances extracellular vesicle secretion and cargo profile. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Watson-levings RS, Palmer GD, Levings PP, Dacanay EA, Evans CH, Ghivizzani SC. Gene Therapy in Orthopaedics: Progress and Challenges in Pre-Clinical Development and Translation. Front Bioeng Biotechnol 2022;10:901317. [DOI: 10.3389/fbioe.2022.901317] [Reference Citation Analysis]
|
| 14 |
Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, Hedayati Asl AA, Abbasi Kakroodi F, Jaroughi N, Mohseni Meybodi MA, Setoodeh A, Abbasi F, Hosseini SE, Moeini Nia F, Salman Yazdi R, Navabi R, Hajizadeh-Saffar E, Baharvand H. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial. Stem Cell Res Ther 2022;13:264. [PMID: 35725652 DOI: 10.1186/s13287-022-02941-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Yoon A, Rivera-cruz C, Gimble JM, Yun C, Figueiredo ML. Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors. Molecular Therapy - Oncolytics 2022;25:78-97. [DOI: 10.1016/j.omto.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Xing Y, Li B, He J, Hua H. Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells. Front Immunol 2022;13:871096. [PMID: 35444638 DOI: 10.3389/fimmu.2022.871096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Cequier A, Romero A, Vázquez FJ, Vitoria A, Bernad E, Fuente S, Zaragoza P, Rodellar C, Barrachina L. Equine Mesenchymal Stem Cells Influence the Proliferative Response of Lymphocytes: Effect of Inflammation, Differentiation and MHC-Compatibility. Animals 2022;12:984. [DOI: 10.3390/ani12080984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Li Y, Gao H, Brunner TM, Hu X, Yan Y, Liu Y, Qiao L, Wu P, Li M, Liu Q, Yang F, Lin J, Löhning M, Shen P. Menstrual blood-derived mesenchymal stromal cells efficiently ameliorate experimental autoimmune encephalomyelitis by inhibiting T cell activation in mice. Stem Cell Res Ther 2022;13:155. [PMID: 35410627 DOI: 10.1186/s13287-022-02838-8] [Reference Citation Analysis]
|
| 19 |
Vandermeulen M, Mohamed-Wais M, Erpicum P, Delbouille MH, Lechanteur C, Briquet A, Maggipinto G, Jouret F, Beguin Y, Detry O. Infusion of Allogeneic Mesenchymal Stromal Cells After Liver Transplantation: A 5-Year Follow-Up. Liver Transpl 2022;28:636-46. [PMID: 34605167 DOI: 10.1002/lt.26323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Shah K, Shah N, Ghassemi F, Ly C, George T, Lutz C, Sumer H, Pan Z. Alloreactivity of Allogeneic Mesenchymal Stem/Stromal Cells and Other Cellular Therapies: A Concise Review. Stem Cells International 2022;2022:1-8. [DOI: 10.1155/2022/9589600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Fraser D, Caton J, Benoit DSW. Periodontal Wound Healing and Regeneration: Insights for Engineering New Therapeutic Approaches. Front Dent Med 2022;3:815810. [DOI: 10.3389/fdmed.2022.815810] [Reference Citation Analysis]
|
| 22 |
Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, Fahmi H, Lewalle P, Fayyad-Kazan M, Merimi M. Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Front Cell Dev Biol 2021;9:716853. [PMID: 35096805 DOI: 10.3389/fcell.2021.716853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 23 |
Keyt LK, Laprade MD, Krych AJ, Saris DBF. Injectable Allogenic Mesenchymal Stromal Cells: Advantages, Disadvantages, and Challenges. Orthobiologics 2022. [DOI: 10.1007/978-3-030-84744-9_6] [Reference Citation Analysis]
|
| 24 |
Haque N, Abu Kasim NH, Soesilawati P, Munadziroh E. Induced pluripotent stem cells–derived dental pulp stem cells. iPSC Derived Progenitors 2022. [DOI: 10.1016/b978-0-323-85545-7.00011-9] [Reference Citation Analysis]
|
| 25 |
Lee J, Lee S, Huh SJ, Kang BJ, Shin H. Directed Regeneration of Osteochondral Tissue by Hierarchical Assembly of Spatially Organized Composite Spheroids. Adv Sci (Weinh) 2022;9:e2103525. [PMID: 34806336 DOI: 10.1002/advs.202103525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Dubuc A, Planat-bénard V, Marty M, Monsarrat P, Kémoun P. Periodontal Cell Therapy: A Systematic Review and Meta-analysis. Periodontitis 2022. [DOI: 10.1007/978-3-030-96881-6_20] [Reference Citation Analysis]
|
| 27 |
Ranjbar A, Hassanzadeh H, Jahandoust F, Miri R, Bidkhori HR, Monzavi SM, Sanjar-Moussavi N, Matin MM, Shariati-Sarabi Z. Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial. Curr Res Transl Med 2021;70:103324. [PMID: 34979487 DOI: 10.1016/j.retram.2021.103324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 28 |
Song L, Zhou R, Xiao J, He L, Zhu F, Li C, Dai F. Demineralized bone matrix combined with cytotoxic T-lymphocyte-associated protein 4 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells and suppresses the activation of T lymphocytes in vitro. J Tissue Eng Regen Med 2021. [PMID: 34965018 DOI: 10.1002/term.3281] [Reference Citation Analysis]
|
| 29 |
Bagno LL, Salerno AG, Balkan W, Hare JM. Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method. Expert Opin Biol Ther 2021;:1-15. [PMID: 34882517 DOI: 10.1080/14712598.2022.2016695] [Reference Citation Analysis]
|
| 30 |
Norte-Muñoz M, Lucas-Ruiz F, Gallego-Ortega A, García-Bernal D, Valiente-Soriano FJ, de la Villa P, Vidal-Sanz M, Agudo-Barriuso M. Neuroprotection and Axonal Regeneration Induced by Bone Marrow Mesenchymal Stromal Cells Depend on the Type of Transplant. Front Cell Dev Biol 2021;9:772223. [PMID: 34805178 DOI: 10.3389/fcell.2021.772223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Mebarki M, Iglicki N, Marigny C, Abadie C, Nicolet C, Churlaud G, Maheux C, Boucher H, Monsel A, Menasché P, Larghero J, Faivre L, Cras A. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases. Stem Cell Res Ther 2021;12:571. [PMID: 34774107 DOI: 10.1186/s13287-021-02637-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Yarygin KN, Namestnikova DD, Sukhinich KK, Gubskiy IL, Majouga AG, Kholodenko IV. Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier? Cells 2021;10:2997. [PMID: 34831220 DOI: 10.3390/cells10112997] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Adamowicz J, Kluth LA, Pokrywczynska M, Drewa T. Tissue Engineering and Its Potential to Reduce Prostate Cancer Treatment Sequelae-Narrative Review. Front Surg 2021;8:644057. [PMID: 34722618 DOI: 10.3389/fsurg.2021.644057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 34 |
Chen CF, Hu CC, Wu CT, Wu HH, Chang CS, Hung YP, Tsai CC, Chang Y. Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trial. Stem Cell Res Ther 2021;12:562. [PMID: 34717765 DOI: 10.1186/s13287-021-02631-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Calcat-I-Cervera S, Sanz-Nogués C, O'Brien T. When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease. Front Med (Lausanne) 2021;8:728496. [PMID: 34616756 DOI: 10.3389/fmed.2021.728496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 36 |
Krampera M, Le Blanc K. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell 2021;28:1708-25. [PMID: 34624232 DOI: 10.1016/j.stem.2021.09.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 37 |
Shaw TD, Krasnodembskaya AD, Schroeder GN, Zumla A, Maeurer M, O'Kane CM. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases. Clin Microbiol Rev 2021;:e0006421. [PMID: 34612662 DOI: 10.1128/CMR.00064-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 38 |
Ghoneim MA, Refaie AF, Elbassiouny BL, Gabr MM, Zakaria MM. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges. Stem Cell Rev Rep 2020;16:1156-72. [PMID: 32880857 DOI: 10.1007/s12015-020-10036-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 39 |
Li B, Xing Y, Gan Y, He J, Hua H. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells. Stem Cell Res Ther 2021;12:478. [PMID: 34446113 DOI: 10.1186/s13287-021-02541-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 40 |
Benavides FP, Pinto GBA, Heckler MCT, Hurtado DMR, Teixeira LR, Monobe MMS, Machado GF, de Melo GD, Rodríguez-Sánchez DN, Alvarenga FDCLE, Amorim RM. Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs. Cell Transplant 2021;30:9636897211034464. [PMID: 34427495 DOI: 10.1177/09636897211034464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Hamilton G, Teufelsbauer M. Adipose-derived stromal/stem cells and extracellular vesicles for cancer therapy. Expert Opin Biol Ther 2021;:1-12. [PMID: 34236014 DOI: 10.1080/14712598.2021.1954156] [Reference Citation Analysis]
|
| 42 |
Roshanbinfar K, Esser TU, Engel FB. Stem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine. Antioxid Redox Signal 2021;35:143-62. [PMID: 32993354 DOI: 10.1089/ars.2020.8193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 43 |
Govindasamy V, Rajendran A, Lee ZX, Ooi GC, Then KY, Then KL, Gayathri M, Kumar Das A, Cheong SK. The potential role of mesenchymal stem cells in modulating antiageing process. Cell Biol Int 2021. [PMID: 34245637 DOI: 10.1002/cbin.11652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 44 |
Chen Y, Yan G, Ma Y, Zhong M, Yang Y, Guo J, Wang C, Han W, Zhang L, Xu S, Huang J, Dai H, Qi Z. Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1/IRF3-regulated-IFN-γ production. Immunol Lett 2021;238:21-8. [PMID: 34228988 DOI: 10.1016/j.imlet.2021.06.007] [Reference Citation Analysis]
|
| 45 |
Jayankura M, Schulz AP, Delahaut O, Witvrouw R, Seefried L, Berg BV, Heynen G, Sonnet W. Percutaneous administration of allogeneic bone-forming cells for the treatment of delayed unions of fractures: a pilot study. Stem Cell Res Ther 2021;12:363. [PMID: 34174963 DOI: 10.1186/s13287-021-02432-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 46 |
Sharma A, Chakraborty A, Jaganathan BG. Review of the potential of mesenchymal stem cells for the treatment of infectious diseases. World J Stem Cells 2021;13:568-93. [PMID: 34249228 DOI: 10.4252/wjsc.v13.i6.568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 47 |
Refaie AF, Elbassiouny BL, Kloc M, Sabek OM, Khater SM, Ismail AM, Mohamed RH, Ghoneim MA. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations. Front Immunol 2021;12:690623. [PMID: 34248981 DOI: 10.3389/fimmu.2021.690623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 48 |
Yoneda T, Choi BH, Gupta PK, Ho CY, Tsui YP, Wang LM, Fujiwara Y, Karasawa H, Moriya Y, Bando K, Kamiyama Y, Kanki M, Omura K, Watanabe T, Bae Y, Chou FC, Ham DS, Lee JY, Liu G, Liu Y, Ooi J, Tsurumaki Y. Non-clinical assessment of cell therapy products: the perspective from five Asian countries/regions based on regulatory guidelines and the underpinning rationales. Cytotherapy 2021:S1465-3249(21)00643-5. [PMID: 34116946 DOI: 10.1016/j.jcyt.2021.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 49 |
Li C, Mills Z, Zheng Z. Novel cell sources for bone regeneration. MedComm (2020) 2021;2:145-74. [PMID: 34766140 DOI: 10.1002/mco2.51] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 50 |
Planat-Benard V, Varin A, Casteilla L. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism. Front Immunol 2021;12:626755. [PMID: 33995350 DOI: 10.3389/fimmu.2021.626755] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 51 |
Watts AE. Complications of Regenerative Medicine. Complications in Equine Surgery 2021. [DOI: 10.1002/9781119190332.ch54] [Reference Citation Analysis]
|
| 52 |
Koh AE, Subbiah SK, Farhana A, Alam MK, Mok PL. Mitigation of Sodium Iodate-Induced Cytotoxicity in Retinal Pigment Epithelial Cells in vitro by Transgenic Erythropoietin-Expressing Mesenchymal Stem Cells. Front Cell Dev Biol 2021;9:652065. [PMID: 33937251 DOI: 10.3389/fcell.2021.652065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 53 |
Zhuang WZ, Lin YH, Su LJ, Wu MS, Jeng HY, Chang HC, Huang YH, Ling TY. Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci 2021;28:28. [PMID: 33849537 DOI: 10.1186/s12929-021-00725-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 20.5] [Reference Citation Analysis]
|
| 54 |
Rangasami VK, Nawale G, Asawa K, Kadekar S, Samanta S, Nilsson B, Ekdahl KN, Miettinen S, Hilborn J, Teramura Y, Varghese OP, Oommen OP. Pluronic Micelle-Mediated Tissue Factor Silencing Enhances Hemocompatibility, Stemness, Differentiation Potential, and Paracrine Signaling of Mesenchymal Stem Cells. Biomacromolecules 2021;22:1980-9. [PMID: 33813822 DOI: 10.1021/acs.biomac.1c00070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 55 |
Chew JRJ, Tan BL, Lu JX, Tong HJ, Duggal MS. Cell-Based Therapy for Tooth Replantation Following Avulsion: A Systematic Review. Tissue Eng Part B Rev 2021. [PMID: 33593127 DOI: 10.1089/ten.TEB.2021.0016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Xie A, Peng Y, Yao Z, Lu L, Ni T. Effect of a subset of adipose-derived stem cells isolated with liposome magnetic beads to promote cartilage repair. J Cell Mol Med 2021;25:4204-15. [PMID: 33768729 DOI: 10.1111/jcmm.16470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 57 |
Harman RM, Marx C, Van de Walle GR. Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy. Front Cell Dev Biol 2021;9:654885. [PMID: 33869217 DOI: 10.3389/fcell.2021.654885] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 58 |
García-Bernal D, García-Arranz M, Yáñez RM, Hervás-Salcedo R, Cortés A, Fernández-García M, Hernando-Rodríguez M, Quintana-Bustamante Ó, Bueren JA, García-Olmo D, Moraleda JM, Segovia JC, Zapata AG. The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy. Front Cell Dev Biol 2021;9:650664. [PMID: 33796536 DOI: 10.3389/fcell.2021.650664] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 59 |
Sarıkaya A, Aydın G, Özyüncü Ö, Şahin E, Uçkan-Çetinkaya D, Aerts-Kaya F. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta.Biotech Histochem. 2021;1-11. [PMID: 33641543 DOI: 10.1080/10520295.2021.1885739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 60 |
Wong KU, Zhang A, Akhavan B, Bilek MM, Yeo GC. Biomimetic Culture Strategies for the Clinical Expansion of Mesenchymal Stromal Cells. ACS Biomater Sci Eng 2021. [PMID: 33599471 DOI: 10.1021/acsbiomaterials.0c01538] [Reference Citation Analysis]
|
| 61 |
Zhang X, Wu S, Zhu Y, Chu CQ. Exploiting Joint-Resident Stem Cells by Exogenous SOX9 for Cartilage Regeneration for Therapy of Osteoarthritis. Front Med (Lausanne) 2021;8:622609. [PMID: 33681252 DOI: 10.3389/fmed.2021.622609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 62 |
Sareen N, Srivastava A, Dhingra S. Role of prostaglandin E2 in allogeneic mesenchymal stem cell therapy for cardiac repair. Can J Physiol Pharmacol 2021;99:140-50. [PMID: 33559528 DOI: 10.1139/cjpp-2020-0413] [Reference Citation Analysis]
|
| 63 |
Berglund AK, Long JM, Robertson JB, Schnabel LV. TGF-β2 Reduces the Cell-Mediated Immunogenicity of Equine MHC-Mismatched Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Immunomodulatory Properties. Front Cell Dev Biol 2021;9:628382. [PMID: 33614658 DOI: 10.3389/fcell.2021.628382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 64 |
Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021;11:234. [PMID: 33477808 DOI: 10.3390/ani11010234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 65 |
Elshaer SL, Park HS, Pearson L, Hill WD, Longo FM, El-Remessy AB. Modulation of p75NTR on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model. Int J Mol Sci 2021;22:E829. [PMID: 33467640 DOI: 10.3390/ijms22020829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Dumitrescu M, Vacaru AM, Trusca VG, Fenyo IM, Ionita R, Gafencu AV. K2 Transfection System Boosts the Adenoviral Transduction of Murine Mesenchymal Stromal Cells. Int J Mol Sci 2021;22:E598. [PMID: 33435318 DOI: 10.3390/ijms22020598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Lopes LLNM, Navarro TP, Dardik A. Introduction to Stem Cell Therapy and Its Application in Vascular Diseases. Stem Cell Therapy for Vascular Diseases 2021. [DOI: 10.1007/978-3-030-56954-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 68 |
Son YB, Bharti D, Kim SB, Bok EY, Lee SY, Ho HJ, Lee SL, Rho GJ. Hematological patterns and histopathological assessment of Miniature Pigs in the experiments on human mesenchymal stem cell transplantation. Int J Med Sci 2021;18:1259-68. [PMID: 33526987 DOI: 10.7150/ijms.53036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 69 |
Marklein RA, Mantay M, Gomillion C, Warnock JN. Biomanufacturing of Mesenchymal Stromal Cells for Therapeutic Applications. Cell Engineering 2021. [DOI: 10.1007/978-3-030-79871-0_9] [Reference Citation Analysis]
|
| 70 |
Bush LM, Healy CP, Javdan SB, Emmons JC, Deans TL. Biological Cells as Therapeutic Delivery Vehicles. Trends Pharmacol Sci 2021;42:106-18. [PMID: 33342562 DOI: 10.1016/j.tips.2020.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 71 |
Fričová D, Korchak JA, Zubair AC. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease. NPJ Regen Med 2020;5:20. [PMID: 33298940 DOI: 10.1038/s41536-020-00106-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 72 |
Robb KP, Juignet L, Morissette Martin P, Walker JT, Brooks CR, Barreira C, Dekaban GA, Flynn LE. Adipose Stromal Cells Enhance Decellularized Adipose Tissue Remodeling Through Multimodal Mechanisms. Tissue Eng Part A 2021;27:618-30. [PMID: 32873224 DOI: 10.1089/ten.TEA.2020.0180] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 73 |
Kremen TJ Jr, Stefanovic T, Tawackoli W, Salehi K, Avalos P, Reichel D, Perez MJ, Glaeser JD, Sheyn D. A Translational Porcine Model for Human Cell-Based Therapies in the Treatment of Posttraumatic Osteoarthritis After Anterior Cruciate Ligament Injury. Am J Sports Med 2020;48:3002-12. [PMID: 32924528 DOI: 10.1177/0363546520952353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 74 |
Kerstan A, Niebergall-Roth E, Esterlechner J, Schröder HM, Gasser M, Waaga-Gasser AM, Goebeler M, Rak K, Schrüfer P, Endres S, Hagenbusch P, Kraft K, Dieter K, Ballikaya S, Stemler N, Sadeghi S, Tappenbeck N, Murphy GF, Orgill DP, Frank NY, Ganss C, Scharffetter-Kochanek K, Frank MH, Kluth MA. Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data. Cytotherapy 2021;23:165-75. [PMID: 33011075 DOI: 10.1016/j.jcyt.2020.08.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 75 |
Sareen N, Abu-El-Rub E, Ammar HI, Yan W, Sequiera GL, ShamsEldeen AM, Moudgil M, Dhingra R, Shokry HS, Rashed LA, Kirshenbaum LA, Dhingra S. Hypoxia-induced downregulation of cyclooxygenase 2 leads to the loss of immunoprivilege of allogeneic mesenchymal stem cells. FASEB J 2020;34:15236-51. [PMID: 32959405 DOI: 10.1096/fj.202001478R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 76 |
White SJ, Chong JJH. Mesenchymal Stem Cells in Cardiac Repair: Effects on Myocytes, Vasculature, and Fibroblasts. Clin Ther 2020;42:1880-91. [PMID: 32938532 DOI: 10.1016/j.clinthera.2020.08.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 77 |
Sienko D, Klimczak-Tomaniak D, Kulesza A, Symonides H, Kuch M, Paczek L, Burdzinska A. The influence of oxygen deprivation and donor age on the effect of statins on human mesenchymal stromal cells. Tissue Cell 2020;67:101427. [PMID: 32911449 DOI: 10.1016/j.tice.2020.101427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 78 |
Abu‐el‐rub E, Sareen N, Lester Sequiera G, Ammar HI, Yan W, Shamseldeen AM, Rubinchik I, Moudgil M, Shokry HS, Rashed LA, Dhingra S. Hypoxia‐induced increase in Sug1 leads to poor post‐transplantation survival of allogeneic mesenchymal stem cells. FASEB j 2020;34:12860-76. [DOI: 10.1096/fj.202000454r] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 79 |
Hu LR, Pan J. Adipose-derived stem cell therapy shows promising results for secondary lymphedema. World J Stem Cells 2020;12:612-20. [PMID: 32843917 DOI: 10.4252/wjsc.v12.i7.612] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 80 |
Tee BC, Sun Z. Xenogeneic mesenchymal stem cell transplantation for mandibular defect regeneration. Xenotransplantation 2020;27:e12625. [PMID: 32629548 DOI: 10.1111/xen.12625] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Cheung TS, Bertolino GM, Giacomini C, Bornhäuser M, Dazzi F, Galleu A. Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers. Front Immunol 2020;11:1338. [PMID: 32670295 DOI: 10.3389/fimmu.2020.01338] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 82 |
Goodman SB, Lin T. Modifying MSC Phenotype to Facilitate Bone Healing: Biological Approaches. Front Bioeng Biotechnol 2020;8:641. [PMID: 32671040 DOI: 10.3389/fbioe.2020.00641] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 83 |
Gharbavi M, Sharafi A, Ghanbarzadeh S. Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy. Curr Gene Ther 2020;20:269-84. [PMID: 32515309 DOI: 10.2174/1566523220666200607190339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 84 |
Lynch K, Treacy O, Chen X, Murphy N, Lohan P, Islam MN, Donohoe E, Griffin MD, Watson L, McLoughlin S, O'Malley G, Ryan AE, Ritter T. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo. Mol Ther 2020;28:2023-43. [PMID: 32531237 DOI: 10.1016/j.ymthe.2020.05.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 85 |
Harrell CR, Jovicic N, Djonov V, Volarevic V. Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics. Pharmaceutics 2020;12:E474. [PMID: 32456070 DOI: 10.3390/pharmaceutics12050474] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 86 |
Chang SH, Kim HJ, Park CG. Allogeneic ADSCs Induce the Production of Alloreactive Memory-CD8 T Cells through HLA-ABC Antigens. Cells 2020;9:E1246. [PMID: 32443511 DOI: 10.3390/cells9051246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 87 |
Usategui-Martín R, Puertas-Neyra K, García-Gutiérrez MT, Fuentes M, Pastor JC, Fernandez-Bueno I. Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration. Mol Ther Methods Clin Dev 2020;17:1155-66. [PMID: 32514411 DOI: 10.1016/j.omtm.2020.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 88 |
Hwang JW, Lee NK, Yang JH, Son HJ, Bang SI, Chang JW, Na DL. A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain. Int J Mol Sci 2020;21:E3052. [PMID: 32357509 DOI: 10.3390/ijms21093052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 89 |
Haworth R, Sharpe M. Accept or Reject: The Role of Immune Tolerance in the Development of Stem Cell Therapies and Possible Future Approaches. Toxicol Pathol 2020;:192623320918241. [PMID: 32319357 DOI: 10.1177/0192623320918241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 90 |
Picken A, Harriman J, Iftimia-mander A, Johnson L, Prosser A, Quirk R, Thomas R. A Monte Carlo framework for managing biological variability in manufacture of autologous cell therapy from mesenchymal stromal cells therapies. Cytotherapy 2020;22:227-38. [DOI: 10.1016/j.jcyt.2020.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 91 |
Harrell CR, Miloradovic D, Sadikot R, Fellabaum C, Markovic BS, Miloradovic D, Acovic A, Djonov V, Arsenijevic N, Volarevic V. Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product "Exo-d-MAPPS" in Attenuation of Chronic Airway Inflammation. Anal Cell Pathol (Amst) 2020;2020:3153891. [PMID: 32257769 DOI: 10.1155/2020/3153891] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 92 |
Tricot T, De Boeck J, Verfaillie C. Alternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand? Cells 2020;9:E566. [PMID: 32121068 DOI: 10.3390/cells9030566] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 93 |
Correia CR, Nadine S, Mano JF. Cell Encapsulation Systems Toward Modular Tissue Regeneration: From Immunoisolation to Multifunctional Devices. Adv Funct Mater 2020;30:1908061. [DOI: 10.1002/adfm.201908061] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 94 |
Chen K, Huang Y, Singh R, Wang ZZ. Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases. J Cell Physiol 2020;235:6257-67. [PMID: 31994198 DOI: 10.1002/jcp.29554] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 95 |
Almeida-Porada G, Atala AJ, Porada CD. Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery. Mol Ther Methods Clin Dev 2020;16:204-24. [PMID: 32071924 DOI: 10.1016/j.omtm.2020.01.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 96 |
Couto PS, Bersenev A, Rafiq QA. Process development and manufacturing approaches for mesenchymal stem cell therapies. Engineering Strategies for Regenerative Medicine 2020. [DOI: 10.1016/b978-0-12-816221-7.00002-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 97 |
Puertas-Neyra K, Usategui-Martín R, Coco RM, Fernandez-Bueno I. Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases. Neural Regen Res 2020;15:1631-8. [PMID: 32209762 DOI: 10.4103/1673-5374.276324] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 98 |
Kuca-Warnawin E, Skalska U, Janicka I, Musiałowicz U, Bonek K, Głuszko P, Szczęsny P, Olesińska M, Kontny E. The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases. Cells 2019;8:E1659. [PMID: 31861245 DOI: 10.3390/cells8121659] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 99 |
Kamm JL, Parlane NA, Riley CB, Gee EK, Dittmer KE, McIlwraith CW. Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression. PLoS One 2019;14:e0225161. [PMID: 31747418 DOI: 10.1371/journal.pone.0225161] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 100 |
Abdelrazik H, Giordano E, Barbanti Brodano G, Griffoni C, De Falco E, Pelagalli A. Substantial Overview on Mesenchymal Stem Cell Biological and Physical Properties as an Opportunity in Translational Medicine. Int J Mol Sci 2019;20:E5386. [PMID: 31671788 DOI: 10.3390/ijms20215386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 101 |
Dias IE, Pinto PO, Barros LC, Viegas CA, Dias IR, Carvalho PP. Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases? BMC Vet Res 2019;15:358. [PMID: 31640767 DOI: 10.1186/s12917-019-2087-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 102 |
Dai GC, Li YJ, Chen MH, Lu PP, Rui YF. Tendon stem/progenitor cell ageing: Modulation and rejuvenation. World J Stem Cells 2019;11:677-92. [PMID: 31616543 DOI: 10.4252/wjsc.v11.i9.677] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 103 |
Chung MJ, Park S, Son JY, Lee JY, Yun HH, Lee EJ, Lee EM, Cho GJ, Lee S, Park HS, Jeong KS. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use. Cell Cycle 2019;18:2954-71. [PMID: 31505996 DOI: 10.1080/15384101.2019.1664224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 104 |
Maruyama M, Lin T, Pan C, Moeinzadeh S, Takagi M, Yang YP, Goodman SB. Cell-Based and Scaffold-Based Therapies for Joint Preservation in Early-Stage Osteonecrosis of the Femoral Head: A Review of Basic Research. JBJS Rev 2019;7:e5-e5. [DOI: 10.2106/jbjs.rvw.18.00202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 105 |
Paton MCB, Allison BJ, Fahey MC, Li J, Sutherland AE, Pham Y, Nitsos I, Bischof RJ, Moss TJ, Polglase GR, Jenkin G, Miller SL, McDonald CA. Umbilical cord blood versus mesenchymal stem cells for inflammation-induced preterm brain injury in fetal sheep. Pediatr Res 2019;86:165-73. [PMID: 30858474 DOI: 10.1038/s41390-019-0366-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 106 |
Wang Y, Tian M, Wang F, Heng BC, Zhou J, Cai Z, Liu H. Understanding the Immunological Mechanisms of Mesenchymal Stem Cells in Allogeneic Transplantation: From the Aspect of Major Histocompatibility Complex Class I.Stem Cells Dev. 2019;28:1141-1150. [PMID: 31215341 DOI: 10.1089/scd.2018.0256] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 107 |
Caplan H, Olson SD, Kumar A, George M, Prabhakara KS, Wenzel P, Bedi S, Toledano-Furman NE, Triolo F, Kamhieh-Milz J, Moll G, Cox CS Jr. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application. Front Immunol 2019;10:1645. [PMID: 31417542 DOI: 10.3389/fimmu.2019.01645] [Cited by in Crossref: 144] [Cited by in F6Publishing: 153] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 108 |
Diedrichs F, Stolk M, Jürchott K, Haag M, Sittinger M, Seifert M. Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies. Front Immunol 2019;10:1716. [PMID: 31396228 DOI: 10.3389/fimmu.2019.01716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 109 |
Kong Y, Zhao Y, Li D, Shen H, Yan M. Dual delivery of encapsulated BM-MSCs and BMP-2 improves osteogenic differentiation and new bone formation. J Biomed Mater Res A 2019;107:2282-95. [PMID: 31152570 DOI: 10.1002/jbm.a.36737] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 110 |
Bislenghi G, Wolthuis A, Van Assche G, Vermeire S, Ferrante M, D'Hoore A. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease. Expert Opin Biol Ther. 2019;19:607-616. [PMID: 31121104 DOI: 10.1080/14712598.2019.1623876] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 111 |
Zhou W, Lin J, Zhao K, Jin K, He Q, Hu Y, Feng G, Cai Y, Xia C, Liu H, Shen W, Hu X, Ouyang H. Single-Cell Profiles and Clinically Useful Properties of Human Mesenchymal Stem Cells of Adipose and Bone Marrow Origin. Am J Sports Med 2019;47:1722-33. [PMID: 31100005 DOI: 10.1177/0363546519848678] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 112 |
Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 2019;8. [PMID: 31100966 DOI: 10.3390/cells8050467] [Cited by in Crossref: 186] [Cited by in F6Publishing: 197] [Article Influence: 46.5] [Reference Citation Analysis]
|
| 113 |
Wang Y, Huang J, Gong L, Yu D, An C, Bunpetch V, Dai J, Huang H, Zou X, Ouyang H, Liu H. The Plasticity of Mesenchymal Stem Cells in Regulating Surface HLA-I. iScience 2019;15:66-78. [PMID: 31030183 DOI: 10.1016/j.isci.2019.04.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 114 |
van Megen KM, van 't Wout ET, Lages Motta J, Dekker B, Nikolic T, Roep BO. Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity. Front Immunol. 2019;10:694. [PMID: 31001285 DOI: 10.3389/fimmu.2019.00694] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 115 |
Ichihashi S, Fernández-colino A, Wolf F, Rojas-gonzález DM, Kichikawa K, Jockenhoevel S, Schmitz-rode T, Mela P. Bio-Based Covered Stents: The Potential of Biologically Derived Membranes. Tissue Engineering Part B: Reviews 2019;25:135-51. [DOI: 10.1089/ten.teb.2018.0207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 116 |
Saldaña L, Bensiamar F, Vallés G, Mancebo FJ, García-Rey E, Vilaboa N. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors. Stem Cell Res Ther 2019;10:58. [PMID: 30760316 DOI: 10.1186/s13287-019-1156-6] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 117 |
Marinaro F, Sánchez-Margallo FM, Álvarez V, López E, Tarazona R, Brun MV, Blázquez R, Casado JG. Meshes in a mess: Mesenchymal stem cell-based therapies for soft tissue reinforcement. Acta Biomater 2019;85:60-74. [PMID: 30500445 DOI: 10.1016/j.actbio.2018.11.042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 118 |
Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng 2019;3:90-104. [PMID: 30944433 DOI: 10.1038/s41551-018-0325-8] [Cited by in Crossref: 144] [Cited by in F6Publishing: 149] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 119 |
Hernandez Schulman I, M. Hare J. Mesenchymal Stromal Cells as a Therapeutic Intervention. Stromal Cells - Structure, Function, and Therapeutic Implications 2019. [DOI: 10.5772/intechopen.78586] [Reference Citation Analysis]
|
| 120 |
Moreno-manzano V, Oltra García E. Culturing Adult Stem Cells for Cell-Based Therapeutics: Neuroimmune Applications. Cell Culture 2019. [DOI: 10.5772/intechopen.80714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 121 |
Rothrauff BB, Pirosa A, Lin H, Sohn J, Langhans MT, Tuan RS. Stem Cell Therapy for Musculoskeletal Diseases. Principles of Regenerative Medicine 2019. [DOI: 10.1016/b978-0-12-809880-6.00054-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 122 |
Robb KP, Fitzgerald JC, Barry F, Viswanathan S. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency. Cytotherapy. 2019;21:289-306. [PMID: 30528726 DOI: 10.1016/j.jcyt.2018.10.014] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 123 |
Schulman IH, Balkan W, Hare JM. Mesenchymal Stem Cell Therapy for Aging Frailty. Front Nutr. 2018;5:108. [PMID: 30498696 DOI: 10.3389/fnut.2018.00108] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 124 |
Millán-Rivero JE, Nadal-Nicolás FM, García-Bernal D, Sobrado-Calvo P, Blanquer M, Moraleda JM, Vidal-Sanz M, Agudo-Barriuso M. Human Wharton's jelly mesenchymal stem cells protect axotomized rat retinal ganglion cells via secretion of anti-inflammatory and neurotrophic factors. Sci Rep 2018;8:16299. [PMID: 30389962 DOI: 10.1038/s41598-018-34527-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 125 |
Rodríguez Sánchez DN, de Lima Resende LA, Boff Araujo Pinto G, de Carvalho Bovolato AL, Possebon FS, Deffune E, Amorim RM. Canine Adipose-Derived Mesenchymal Stromal Cells Enhance Neuroregeneration in a Rat Model of Sciatic Nerve Crush Injury. Cell Transplant 2019;28:47-54. [PMID: 30369261 DOI: 10.1177/0963689718809045] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 126 |
Magne B, Lataillade JJ, Trouillas M. Mesenchymal Stromal Cell Preconditioning: The Next Step Toward a Customized Treatment For Severe Burn. Stem Cells Dev 2018;27:1385-405. [PMID: 30039742 DOI: 10.1089/scd.2018.0094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 127 |
Schulze J, Sasse S, Prenzler N, Staecker H, Mellott AJ, Roemer A, Durisin M, Lenarz T, Warnecke A. Microenvironmental support for cell delivery to the inner ear. Hear Res 2018;368:109-22. [PMID: 29945803 DOI: 10.1016/j.heares.2018.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 128 |
Barrachina L, Remacha AR, Romero A, Zaragoza P, Vázquez FJ, Rodellar C. Differentiation of equine bone marrow derived mesenchymal stem cells increases the expression of immunogenic genes. Veterinary Immunology and Immunopathology 2018;200:1-6. [DOI: 10.1016/j.vetimm.2018.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 129 |
Zayed M, Adair S, Ursini T, Schumacher J, Misk N, Dhar M. Concepts and challenges in the use of mesenchymal stem cells as a treatment for cartilage damage in the horse. Res Vet Sci 2018;118:317-23. [PMID: 29601969 DOI: 10.1016/j.rvsc.2018.03.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 130 |
Vu NB, Le PT, Truong NC, Van Pham P. Off-the-Shelf Mesenchymal Stem Cell Technology. Stem Cell Drugs - A New Generation of Biopharmaceuticals 2018. [DOI: 10.1007/978-3-319-99328-7_7] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
